Cite
Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
MLA
Zheng, Shuting, et al. “Proton Pump Inhibitor-Enhanced Nanocatalytic Ferroptosis Induction for Stimuli-Responsive Dual-Modal Molecular Imaging Guided Cancer Radiosensitization.” Acta Biomaterialia, vol. 162, May 2023, pp. 72–84. EBSCOhost, https://doi.org/10.1016/j.actbio.2023.03.011.
APA
Zheng, S., Hu, H., Hou, M., Zhu, K., Wu, Z., Qi, L., Xia, H., Liu, G., Ren, Y., Xu, Y., Yan, C., & Zhao, B. (2023). Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization. Acta Biomaterialia, 162, 72–84. https://doi.org/10.1016/j.actbio.2023.03.011
Chicago
Zheng, Shuting, Honglei Hu, Meirong Hou, Kai Zhu, Zede Wu, Li Qi, Hui Xia, et al. 2023. “Proton Pump Inhibitor-Enhanced Nanocatalytic Ferroptosis Induction for Stimuli-Responsive Dual-Modal Molecular Imaging Guided Cancer Radiosensitization.” Acta Biomaterialia 162 (May): 72–84. doi:10.1016/j.actbio.2023.03.011.